emeis Société anonyme (EPA:EMEIS)
France · Delayed Price · Currency is EUR 14.63
-0.44 (-2.92%)
Oct 16, 2025, 4:45 PM CET
emeis Société anonyme Revenue
emeis Société anonyme had revenue of 2.91B EUR in the half year ending June 30, 2025, with 14.53% growth. This brings the company's revenue in the last twelve months to 5.77B, up 6.30% year-over-year. In the year 2024, emeis Société anonyme had annual revenue of 5.64B with 8.43% growth.
Revenue (ttm)
5.77B
Revenue Growth
+6.30%
P/S Ratio
0.42
Revenue / Employee
69.13K
Employees
83,494
Market Cap
2.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.64B | 438.04M | 8.43% |
| Dec 31, 2023 | 5.20B | 516.86M | 11.04% |
| Dec 31, 2022 | 4.68B | 382.33M | 8.89% |
| Dec 31, 2021 | 4.30B | 376.18M | 9.59% |
| Dec 31, 2020 | 3.92B | 182.18M | 4.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |
emeis Société anonyme News
- 14 days ago - Emeis (WBO:ORP2) Half Year 2025 Earnings Call Highlights: Strong Revenue Growth and Financial ... - GuruFocus
- 15 days ago - emeis Société anonyme (ORPEF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Who is Emeis and where are their Irish care homes located? - The Irish Times
- 2 years ago - ORPEA: THIRD-QUARTER 2023 REVENUE AND BUSINESS PLAN UPDATE - Business Wire
- 2 years ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orpea SA - ORPEF - PRNewsWire
- 2 years ago - Orpea shares jump on Q4 revenue and cash boost - Reuters
- 2 years ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Orpea SA - ORPEF - Newsfile Corp
- 2 years ago - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Orpea SA (ORPEF) Investigation - Business Wire